Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/10/2013US8604190 Hetero isonipecotic modulators of vanilloid VR1 receptor
12/10/2013US8604159 Method for preparing functionalized polymers from polymer alcohols
12/10/2013US8604086 Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of HPV
12/10/2013US8604085 Bupropion hydrobromide polymorphs
12/10/2013US8604084 Method
12/10/2013US8604083 Method for the treatment of metabolic disorders
12/10/2013US8604081 Topical composition containing ibuprofen
12/10/2013US8604080 High dose glycine as a treatment for obsessive-compulsive disorder and obsessive compulsive spectrum disorders
12/10/2013US8604079 Solid cosmetic composition
12/10/2013US8604077 Ketal compounds from polyols and oxocarboxylates
12/10/2013US8604076 Method for producing a pharmaceutical composition comprising rotigotine
12/10/2013US8604075 Methods and compositions for improving cognitive function
12/10/2013US8604074 Pro-neurogenic compounds
12/10/2013US8604073 Antimicrobial composition
12/10/2013US8604072 Treatment using dantrolene
12/10/2013US8604071 Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes
12/10/2013US8604070 Use of inhibitors of the renin-angiotensin system
12/10/2013US8604069 Amide compound and medicinal use thereof
12/10/2013US8604068 Insecticidal compositions of 2-cyanobenzene sulfonamide compounds and isomeric forms thereof having improved effect
12/10/2013US8604067 ITE for cancer intervention and eradication
12/10/2013US8604066 Composition that comprises at least one oxime and its use in therapeutics
12/10/2013US8604065 Pyridyl cyanoguanidine derivatives
12/10/2013US8604064 Process for the preparation of roflumilast
12/10/2013US8604063 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
12/10/2013US8604062 Process for the preparation of isoxazolyl-methoxy nicotinic acids
12/10/2013US8604061 2-aminooxazolines as TAAR1 ligands
12/10/2013US8604060 Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases
12/10/2013US8604059 Thioxanthene derivatives for the treatment of infectious diseases
12/10/2013US8604058 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
12/10/2013US8604057 Compositions for preventing and/or treating lysosomal storage disorders
12/10/2013US8604056 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
12/10/2013US8604055 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
12/10/2013US8604054 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
12/10/2013US8604053 TRPV1 antagonists
12/10/2013US8604052 Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof
12/10/2013US8604051 Thieno-pyridine derivatives as MEK inhibitors
12/10/2013US8604050 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
12/10/2013US8604049 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
12/10/2013US8604048 Pyridocarbazole type compounds and applications thereof
12/10/2013US8604047 Method and composition for treating nodulocystic and conglobate acne vulgaris
12/10/2013US8604046 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
12/10/2013US8604045 Pyrimidylaminobenzamide derivatives for treatment of neurofibromatosis
12/10/2013US8604044 Quinazoline based EGFR inhibitors containing a zinc binding moiety
12/10/2013US8604043 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
12/10/2013US8604041 Method of treating panic disorder
12/10/2013US8604039 Dihydrothienopyrimidines for the treatment of inflammatory diseases
12/10/2013US8604038 Pyrrolidine derived beta 3 adrenergic receptor agonists
12/10/2013US8604037 Therapeutic agents useful for treating pain
12/10/2013US8604036 Pyridazinone derivatives
12/10/2013US8604035 Fluoroergoline analogs
12/10/2013US8604034 Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections
12/10/2013US8604033 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
12/10/2013US8604032 Chemical compounds, compositions and methods for kinase modulation
12/10/2013US8604031 Intracellular kinase inhibitors
12/10/2013US8604030 Fused piperidine compound and pharmaceutical containing same
12/10/2013US8604029 2-[(2-substituted)-indolizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
12/10/2013US8604028 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
12/10/2013US8604027 Cyclic progestin regimens and kits
12/10/2013US8604026 Use of kiralaxyl for protecting phytopathogens, and corresponding methods and compositions
12/10/2013US8604025 Heterocyclic sulfonamides
12/10/2013US8604023 1,4-benzodiazepinone compounds and their use in treating cancer
12/10/2013US8604022 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
12/10/2013US8604021 Substituted arylamine compounds and methods of treatment
12/10/2013US8604020 Fluoroquinolone carboxylic acid molecular crystals
12/10/2013US8604019 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
12/10/2013US8604018 Alpha-helix mimetics and methods relating to the treatment of fibrosis
12/10/2013US8604017 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/10/2013US8604015 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
12/10/2013US8604014 Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use
12/10/2013US8604013 Enhanced erythropoiesis and iron metabolism
12/10/2013US8604012 Enhanced erythropoiesis and iron metabolism
12/10/2013US8604011 Therapy for treatment of chronic degenerative brain diseases and nervous system injury
12/10/2013US8604010 Method for producing high sapogenin content composition
12/10/2013US8604009 (20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22-dimethyl-1α,25-hydroxyvitamin D3
12/10/2013US8604008 2-methylene-19,21-dinor-1α-hydroxy-bishomopregnacalciferol
12/10/2013US8604007 Salts of isophosphoramide mustard and analogs thereof
12/10/2013US8604005 Use of probiotics
12/10/2013US8604004 Moenomycin analogs, methods of synthesis, and uses thereof
12/10/2013US8604003 Promoter for hard tissue formation
12/10/2013US8604002 Saccharide antifreeze compositions
12/10/2013US8604001 Use of sulfated oligosaccharides as slimming cosmetic ingredients
12/10/2013US8604000 Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent
12/10/2013US8603999 Amphiphile prodrugs
12/10/2013US8603998 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
12/10/2013US8603997 siRNA that inhibits WT1 gene expression and uses thereof
12/10/2013US8603991 Individualized cancer therapy
12/10/2013US8603990 Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation
12/10/2013US8603989 Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
12/10/2013US8603981 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
12/10/2013US8603980 Glutamate receptor antagonists and methods of use
12/10/2013US8603947 (4-haloalkyl-3-thiobenzoyl)cyclohexanediones and use thereof as herbicides
12/10/2013US8603945 Methods and compositions for providing salicyclic acid-independent pathogen resistance in plants
12/10/2013US8603816 SMAC mimetic
12/10/2013US8603814 Method of inhibiting nonsense-mediated mRNA decay
12/10/2013US8603778 Anti-TNF antibodies, compositions, methods and uses
12/10/2013US8603634 End-capped poly(ester amide) copolymers
12/10/2013US8603546 Herbal supplement for increased muscle strength and endurance for athletes
12/10/2013US8603539 Compositions for drug delivery
12/10/2013US8603538 Process for the production of an n-butyric acid compound in micro encapsulated form, for animal or human consumption
12/10/2013US8603535 Stable formulations for lyophilizing therapeutic particles
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 7860